May 14, 2018 – One-year outcomes of patients undergoing chronic total occlusion (CTO) percutaneous coronary intervention (PCI) treated with zotarolimus-eluting stents (ZES) showed positive outcomes in the PERSPECTIVE trial.[1] Results of the study were presented as late-breaking clinical science at the 2018 Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions. 

The Society for Cardiovascular Angiography and Interventions (SCAI) announced the launch of the SCAI PAD Diagnosis and Treatment Resource Center. This center will be an ongoing, patient-centered quality improvement initiative focused on helping increase peripheral artery disease (PAD) awareness in the cardiovascular and internal medicine community by delving into the underlying risks of this disease state.

May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients hospitalized with endocarditis has increased dramatically over the last decade in a pattern that mirrors the increase in mixed drug use. The nearly decade-long retrospective study analyzed patients in the epicenter of the opioid epidemic — West Virginia. Findings showed a trend between the significant increase in patients hospitalized with endocarditis from mixed drug abuse and the substantial cost it has on state and federal programs.

May 14, 2018 — Diagnostic and Interventional Cardiology (DAIC) magazine was honored with a Silver national Azbee Award for editorial excellence at the 2018 National American Society of Business Publication Editors (ASBPE)  Azbee Awards of Excellence banquet in May in Washington, D.C.  DAIC and Editor Dave Fornell were recognized in the Online Blog Analysis/Commentary category for Fornell’s blog series “Insights Into Cardiovascular Technology Advances.”